1. Home
  2. HTCR vs GRDX Comparison

HTCR vs GRDX Comparison

Compare HTCR & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$0.23

Market Cap

6.5M

Sector

Technology

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$2.06

Market Cap

7.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTCR
GRDX
Founded
2009
N/A
Country
Japan
United Kingdom
Employees
N/A
2
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HTCR
GRDX
Price
$0.23
$2.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
385.6K
112.2K
Earning Date
03-30-2026
04-08-2026
Dividend Yield
56.77%
N/A
EPS Growth
66.67
N/A
EPS
N/A
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.22
$1.92
52 Week High
$1.66
$5.30

Technical Indicators

Market Signals
Indicator
HTCR
GRDX
Relative Strength Index (RSI) 36.78 39.20
Support Level $0.22 $2.03
Resistance Level $0.30 $2.84
Average True Range (ATR) 0.02 0.24
MACD -0.00 0.01
Stochastic Oscillator 11.50 12.20

Price Performance

Historical Comparison
HTCR
GRDX

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: